• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Neurology

Contribution of dementia to US mortality rates drastically underestimated in standard mortality statistics

byJack LennonandAlex Chan
September 1, 2020
in Neurology, Psychiatry
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. Causes of death reported on death certificates drastically underestimated dementia mortality burden by a factor of 2.7.

2. Non-Hispanic Black persons demonstrated significantly greater mortality burden than non-Hispanic White persons.

Evidence Rating Level: 2 (Good)

Dementia is a leading cause of death in the US and abroad, with Alzheimer’s disease accounting for approximately 80% of dementia cases. However, vital statistics are generally the method through which we determine mortality burden. Due to evidence suggesting that dementia is often underreported on death certificates, it is important to shift focus to population-based samples. This prospective cohort study of the Health and Retirement Study assessed noninstitutionalized individuals at baseline in 2000 and follow-up until 2009. A total of 7,342 adults (60.3% female) between the ages of 70 and 99 years were interviewed and included in the study. Three ten-year age groups were established to determine the representation of the sample: 70-79 (64.0%), 80-89 (31.0%), 90-99 (5.0%). The total percentage of deaths attributable to dementia was 13.6% (95% CI 12.2 to 15.0). The mortality burden of dementia was significantly higher among adults with less than a high school education (16.2%, 95% CI 13.2 to 19.0) compared to individuals with a college education (9.8%, 95% CI 7.0 to 12.5). This burden was also significantly greater among non-Hispanic Black individuals (24.7%, 95% CI 17.3 to 31.4) compared to non-Hispanic White person (12.2%, 95% CI 10.7 to 13.6). Causes of deaths reported on death certificates (5.0%, 95% CI 4.3 to 5.8) drastically underestimated dementia’s contribution to mortality in the US by a factor of 2.7. When incorporating deaths due to cognitive impairment without dementia, underestimation of dementia mortality burden was even greater. Overall, this study suggests that the standard mortality statistics utilized to determine dementia mortality burden may be significantly underestimated, calling for a need to incorporate population-based studies and interventions.

Click to read the study in JAMA Neurology

Image: PD

©2020 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

RELATED REPORTS

The 2 Minute Medicine Podcast Episode 6

#VisualAbstract: Lecanemab reduced cognitive and functional decline in early Alzheimer’s disease compared to placebo

Lecanemab may slow cognitive decline in early Alzheimer’s disease

Tags: Alzheimer’s diseasedementianeurologypsychiatry
Previous Post

Colchicine may lower the risk of cardiovascular events in patients with coronary disease

Next Post

Chest radiograph neural network predicts lung cancer in smokers

RelatedReports

2MM Podcast

The 2 Minute Medicine Podcast Episode 6

January 13, 2023
#VisualAbstract: Lecanemab reduced cognitive and functional decline in early Alzheimer’s disease compared to placebo
StudyGraphics

#VisualAbstract: Lecanemab reduced cognitive and functional decline in early Alzheimer’s disease compared to placebo

January 12, 2023
Free alternatives comparable to Mini-Mental State Examination
Chronic Disease

Lecanemab may slow cognitive decline in early Alzheimer’s disease

January 10, 2023
The Scan by 2 Minute Medicine®:  Ultra-Trail du Mont-Blanc, Taylor Swift, NBA rookie Chet Holmgren and Magic Mushrooms!
The Scan by 2 Minute Medicine®

The Scan by 2 Minute Medicine®: The Genetics of Alzheimer’s Disease, the Silent Killer, a Holiday Blizzard and an HIV Vaccine on the Horizon

January 11, 2023
Next Post
Severity of emphysema on pulmonary CT may predict lung cancer location

Chest radiograph neural network predicts lung cancer in smokers

#VisualAbstract: Better glucose control with closed-loop system in children with type 1 diabetes

#VisualAbstract: For-profit long term care homes associated with increased extent of COVID-19 outbreaks and related mortality

Prescription of antibiotics for acute respiratory infections increasing

Proadrenomedullin predicts severe community-acquired pneumonia among children

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Chronic obstructive pulmonary disease associated with worse postoperative outcomes
  • Empagliflozin use is associated with slower progression of chronic kidney disease
  • Diagnostic tool may help identify cerebral palsy regardless of encephalopathy features
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options